Hidron, AI, Edwards, JR, Patel, J, et al.
Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol
Wisplinghoff, H, Bischoff, T, Tallent, SM, Seifert, H, Wenzel, RP, Edmond, MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis
Deshpande, LM, Fritsche, TR, Moet, GJ, Biedenbach, DJ, Jones, RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis
National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control
Scott, RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention. Published March 2009. http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf. Accessed November 5, 2011.
Klevens, RM, Edwards, JR, Richards, CL Jr, et al.
Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep
Carmeli, Y, Eliopoulos, G, Mozaffari, E, Samore, M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med
Song, X, Srinivasan, A, Plaut, D, Perl, TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol
Reik, R, Tenover, FC, Klein, E, McDonald, LC. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis
Song, JH, Ko, KS, Suh, JY, et al.
Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phe-notype and vanA genotype. J Antimicrob Chemother
DiazGranados, CA, Zimmer, SM, Klein, M, Jernigan, JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis
Garbutt, JM, Ventrapragada, M, Littenberg, B, Mundy, LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis
Lucas, GM, Lechtzin, N, Puryear, DW, Yau, LL, Flexner, CW, Moore, RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis
Vergis, EN, Hayden, MK, Chow, JW, et al.
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med
Bhavnani, SM, Drake, JA, Forrest, A, et al.
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis
Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control
Boucher, HW, Talbot, GH, Bradley, JS, et al.
Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America. Clin Infect Dis
Quale, J, Landman, D, Saurina, G, Atwood, E, DiTore, V, Patel, K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis
Bradley, SJ, Wilson, AL, Allen, MC, Sher, HA, Goldstone, AH, Scott, GM. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother
Montecalvo, MA, Jarvis, WR, Uman, J, et al.
Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med
Smith, DW. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy
1999;19(8 pt 2):129S–132S; discussion 133S-137S.
Manzella, J, Benenson, R, Pellerin, G, et al.
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia. Infect Control Hosp Epidemiol
May, AK, Melton, SM, McGwin, G, Cross, JM, Moser, SA, Rue, LW. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock
Nourse, C, Byrne, C, Murphy, H, Kaufmann, ME, Clarke, A, Butler, K. Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect
Puzniak, LA, Mayfield, J, Leet, T, Kollef, M, Mundy, LM. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis
Lautenbach, E, LaRosa, LA, Marr, AM, Nachamkin, I, Bilker, WB, Fishman, NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis
Loeffler, JM, Garbino, J, Lew, D, Harbarth, S, Rohner, P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis
Paterson, DL. “Collateral damage” from cephalosporin or quin-olone antibiotic therapy. Clin Infect Dis
2004;38(suppl 4): S341–S345.
Empey, KM, Rapp, RP, Evans, ME. The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy
Donskey, CJ, Chowdhry, TK, Hecker, MT, et al.
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med
Donskey, CJ, Hoyen, CK, Das, SM, Helfand, MS, Hecker, MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol
Paterson, DL, Muto, CA, Ndirangu, M, et al.
Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens. Antimicrob Agents Chemother
Donskey, CJ, Hanrahan, JA, Hutton, RA, Rice, LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis
Lakticova, V, Hutton-Thomas, R, Meyer, M, Gurkan, E, Rice, LB. Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora. Antimicrob Agents Chemother
Rice, LB, Lakticova, V, Helfand, MS, Hutton-Thomas, R. In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multi-resistant enterococci. J Infect Dis
Rice, LB, Hutton-Thomas, R, Lakticova, V, Helfand, MS, Donskey, CJ. β-Lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis
Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control
Fridkin, SK, Edwards, JR, Courval, JM, et al.
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med
Kritsotakis, EI, Christidou, A, Roumbelaki, M, Tselentis, Y, Gikas, A. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect
Harbarth, S, Cosgrove, S, Carmeli, Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother
Harris, AD, Karchmer, TB, Carmeli, Y, Samore, MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis
Carmeli, Y, Eliopoulos, GM, Samore, MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus
. Emerg Infect Dis
Ostrowsky, BE, Venkataraman, L, D'Agata, EM, Gold, HS, DeGirolami, PC, Samore, MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med
Carmeli, Y, Samore, MH, Huskins, C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med
de Bruin, MA, Riley, LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? a systematic review. BMC Infect Dis
Guggenbichler, JP, Kofler, J, Allerberger, F. The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection
Donskey, CJ, Hume, ME, Callaway, TR, Das, SM, Hoyen, CK, Rice, LB. Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture containing human stool flora. J Infect Dis
Winston, LG, Charlebois, ED, Pang, S, Bangsberg, DR, Perdreau-Remington, F, Chambers, HE
Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control
Bonten, MJ, Slaughter, S, Ambergen, AW, et al.
The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med
Aldeyab, MA, Harbarth, S, Vernaz, N, et al.
Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium dijficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother
Kaier, K, Frank, U. Relationship between antibiotic consumption and Clostridium dijficile-associated diarrhea: an epidemiological note. Antimicrob Agents Chemother
McKinnell, JA, Powderly, AL, Kunz, DF, Patel, M. Individual antimicrobials and risk of VRE colonization. Presented at: 48th Annual Meeting of the Infectious Diseases Society of America; Vancouver; October 21-24, 2010. Abstract 3365.
Ramsey, AM, Zilberberg, MD. Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol
Huskins, WC, Huckabee, CM, O'Grady, NP, et al.
Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med